NASDAQ:ROKA (ROKA) (ROKA) Stock Price, News & Analysis → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free ROKA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$0.65▼$0.6950-Day Range N/A52-Week Range$0.60▼$6.20Volume242,292 shsAverage Volume371,374 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ROKA) alerts: Email Address Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here About (ROKA) Stock (NASDAQ:ROKA)Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… ROKA Stock News HeadlinesMarch 28, 2024 | msn.comWe’ve managed to find an affordable Michelin-star restaurant in LondonMarch 25, 2024 | msn.comThe 6 best places to buy prescription sunglasses online (and save money)March 28, 2024 | Behind the Markets (Ad)Urgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.March 25, 2024 | msn.comConcert lineups for Botanic Gardens, Levitt Pavilion and City Park Jazz in 2024March 25, 2024 | msn.comDCI Accused of Protecting Tycoons & Land GrabbersMarch 21, 2024 | msn.comAmazon Big Spring Sale — CamelBak, The North Face and Sweaty Betty running apparel from $10March 20, 2024 | msn.comDenver’s City Park Jazz 2024 summer free concert lineup releasedMarch 19, 2024 | msn.comThe net worth of Anant Ambani and Radhika MerchantMarch 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. March 18, 2024 | msn.comAaradhya Bachchan looks like a spitting image of her mom Aishwarya Rai Bachchan as the latter remembers her father Krishnaraj Rai on his death anniversary with a note - PICS insideMarch 17, 2024 | msn.comKhushi Kapoor and Ibrahim Ali Khan SPOTTED shooting for 'Naadaniyaan' at Pune universityMarch 16, 2024 | msn.comThrowback! When Aishwarya Rai revealed Amitabh and Jaya Bachchan did her roka with Abhishek Bachchan while her dad Krishnaraj Rai was out of townMarch 15, 2024 | msn.comSon of former Vice President Nanda Bahadur Pun arrested again in gold smuggling caseMarch 14, 2024 | msn.comBigg Boss 10’s Antara Biswas aka Monalisa amazes fans in a gorgeous red and green ethnic lookMarch 13, 2024 | msn.comSurbhi Chandna and Karan Sharma recreate their Roka theme during haldi ceremony in Jaipur, opt for a vibrant look - See PicturesMarch 13, 2024 | msn.comKriti Kharbanda - Pulkit Samrat Wedding: Pastel Colour Outfits to Guest List, Here’s Everything You Need To KnowMarch 13, 2024 | msn.comExclusive! It feels great to be married to Harsh after being in a relationship for six years: Twinkle VasishtMarch 12, 2024 | msn.comPulkit Samrat and Kriti Kharbanda To Get Married In THIS Grand Hotel, Here’s What We KnowMarch 12, 2024 | msn.comInside Pulkit Samrat Kriti Kharbanda's Majestic Wedding Venue In ITC Grand Bharat, Manesar with Jaw-Dropping Interiors | PicsMarch 12, 2024 | msn.comThe mine that sparked a civil war but could bankroll the world’s next nationMarch 11, 2024 | msn.comPICS: Kriti Kharbanda-Pulkit Samrat’s Mumbai house lights up ahead of their wedding in DelhiMarch 11, 2024 | msn.comYour Guide to Ramadan 2024 in Saudi ArabiaMarch 11, 2024 | msn.comSurbhi Chandna Reveals Why She Avoided Looking At Her Parents During Wedding CeremonyMarch 10, 2024 | msn.comWATCH: Music composer turns Radhika Merchant's 'Ekdum Krishna lage che' moment during Jamnagar anna seva into a viral songMarch 9, 2024 | msn.comBand, baaja before baraat: Pre-wedding bashes get bigger, fatterMarch 9, 2024 | msn.comRadhika Merchant's 'ekdam Krishna lage che' remark during anna seva gets a musical makeoverMarch 8, 2024 | msn.comPulkit Samrat and Kriti Kharbanda to marry in Delhi, `Fukrey` team to attendSee More Headlines Receive ROKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/11/2017Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ROKA CUSIPN/A CIK1472343 Webwww.rokabio.com Phone+1-908-6054700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesPaul G. Thomas (Age 61)Chairman of the Board Mary Duseau (Age 52)President, Chief Executive Officer, Secretary, Director Lars Boesgaard (Age 47)Chief Financial Officer, Vice President, Treasurer Nicholas J. Valeriani (Age 60)Director Michael P. Doyle Ph.D. (Age 67)Independent Director David W. J. McGirr (Age 62)Independent Director More Executives ROKA Stock Analysis - Frequently Asked Questions How were (ROKA)'s earnings last quarter? (ROKA) (NASDAQ:ROKA) issued its earnings results on Thursday, May, 11th. The medical research company reported ($1.53) EPS for the quarter, missing the consensus estimate of ($1.19) by $0.34. The medical research company earned $2.04 million during the quarter. What other stocks do shareholders of (ROKA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ROKA) investors own include Credit Suisse High Yield Bond Fund (DHY), Western Asset High Income Fund II (HIX), Twitter (TWTR), Corbus Pharmaceuticals (CRBP), STAG Industrial (STAG), Invesco Senior Income Trust (VVR), Invesco Senior Loan ETF (BKLN), Fibrocell Science (FCSC), Gladstone Investment (GAIN) and Granite Oil (GXOCF). This page (NASDAQ:ROKA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingFed launches fourth dollar overhaulStansberry Research“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ROKA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.